Evidence map›Paper›PMID 39428756›Full record

ArticleJournal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG2025

Bridging the gap through telemedicine: Pilot study on the acceptance and use of teledermatology for urticaria.

Michael Hindelang, Sebastian Sitaru, Chiara Fischer, Tilo Biedermann, Alexander Zink

Abstract read
In one paragraph

Article in Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Patient and physician satisfaction with video consultations in dermatology: An exploratory cross-sectional study.Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Bridging the gap through telemedicine: Pilot study on the acceptance and use of teledermatology for urticaria.Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Michael HindelangDepartment of Dermatology and Allergy, Technical University of Munich, School of Medicine and Health, Munich, Germany.ORCID 0000-0003-2856-8645
Sebastian SitaruDepartment of Dermatology and Allergy, Technical University of Munich, School of Medicine and Health, Munich, Germany.ORCID 0000-0001-7324-9139
Chiara FischerDepartment of Dermatology and Allergy, Technical University of Munich, School of Medicine and Health, Munich, Germany.
Tilo BiedermannDepartment of Dermatology and Allergy, Technical University of Munich, School of Medicine and Health, Munich, Germany.
Alexander ZinkDepartment of Dermatology and Allergy, Technical University of Munich, School of Medicine and Health, Munich, Germany.ORCID 0000-0001-9313-6588

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundChronic spontaneous urticaria (CSU) significantly impairs patients' quality of life. Despite advances in diagnosis and therapy, treatment is still unsatisfactory. Telemedicine offers a promising solution to improve treatment. This pilot study assesses the acceptability and utilization of a digital health model for CSU, examines its impact on disease management, and identifies technical challenges. PATIENTS AND

methodsIn this prospective pilot study, CSU patients at a university hospital in Germany were included. Over 12 months, participants interacted with physicians via a telemedicine platform, which was the study-specific intervention. After each three-month digital visit, symptoms and quality of life were assessed using electronic patient reported outcomes (ePROs) and online questionnaires. In the end, patients and doctors rated the overall satisfaction, the user-friendliness of the platform and the technical challenges.

results24 patients completed the study. The majority (92%) reported that the digital concept could be a promising alternative to traditional consultations. Analysis from baseline to end of study revealed that disease control remained stable while quality of life improved. All physicians found the digital application reliable and time-saving.

conclusionsThis pilot study demonstrates the feasibility and high acceptance of a digital health model for the management of CSU. Further research with larger cohorts is needed and planned to determine broader applicability.

Indexed as

DermatologyQuality of LifeTelemedicineAdultAgedChronic UrticariaFemaleGermanyHumansMaleMiddle AgedPatient Acceptance of Health CarePatient SatisfactionPilot ProjectsProspective StudiesChronic Urticariateledermatologytelemedicineurticaria control test

Identifiers

PMID39428756
PMCPMC11711928

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.